(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
CHRONIC POST-TRAUMATIC NEUROPATHIC PAIN IN ANKLE AND FOOT
University Health Network, TorontoSmall moleculeEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the CHRONIC POST-TRAUMATIC NEUROPATHIC PAIN IN ANKLE AND FOOT cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- Uppsala University | Phase 2 | B |
Ethosuximide University Hospital, Clermont-Ferrand | Phase 2 | B |
Fampridine John Elfar | Phase 2/3 | B |
VENLOR Uppsala University | Phase 2 | B |
Neuron012703 Targeted Medical Pharma | Phase 2 | NR |
Same molecule, other indications
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →